This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Croles FN, Nasserinejad K, Duvekot JJ, Kruip MJ, Meijer K, Leebeek FW. Pregnancy, thrombophilia, and the risk of a first venous thrombosis: systematic review and bayesian meta-analysis. BMJ. 2017; 359: j4452.CrolesFNNasserinejadKDuvekotJJKruipMJMeijerKLeebeekFWPregnancy, thrombophilia, and the risk of a first venous thrombosis: systematic review and bayesian meta-analysis2017359j445210.1136/bmj.j4452565746329074563Search in Google Scholar
Seligsohn U, Lubetsky A. Medical progress: Genetic susceptibility to venous thrombosis. N Engl J Med. 2001; 344(16): 1222–1231.SeligsohnULubetskyAMedical progress: Genetic susceptibility to venous thrombosis2001344161222123110.1056/NEJM20010419344160711309638Search in Google Scholar
Roozbeh N, Banihashemi F, Mehraban M, Abdi F. Potential role of Factor V Leiden mutation in adverse pregnancy outcomes: An updated systematic review. Biomed Res Ther. 2017; 4(12): 1832–1846.RoozbehNBanihashemiFMehrabanMAbdiFPotential role of Factor V Leiden mutation in adverse pregnancy outcomes: An updated systematic review20174121832184610.15419/bmrat.v4i12.389Search in Google Scholar
Cernera G, Di Minno A, Amato F, Elce A, Liguori R, Bruzzese D, et al. Molecular analysis of prothrombotic gene variants in venous thrombosis: A potential role for sex and thrombotic localization. J Clin Med. 2020; 9(4): 1008.CerneraGDi MinnoAAmatoFElceALiguoriRBruzzeseDMolecular analysis of prothrombotic gene variants in venous thrombosis: A potential role for sex and thrombotic localization202094100810.3390/jcm9041008723122132252449Search in Google Scholar
Alsayegh F, Al-Jassar W, Wani S, Tahlak M, Albahar A, Al Kharusi L, et al. Venous thromboembolism risk and adequacy of prophylaxis in high risk pregnancy in the Arabian Gulf. Curr Vasc Pharmacol. 2016; 14(4): 368–373.AlsayeghFAl-JassarWWaniSTahlakMAlbaharAAl KharusiLVenous thromboembolism risk and adequacy of prophylaxis in high risk pregnancy in the Arabian Gulf201614436837310.2174/1570161113666151030105431499793026517701Search in Google Scholar
James AH, Jamison MG, Brancazio LR, Myers ER. Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality. Am J Obstet Gynecol. 2006; 194(5): 1311–1315.JamesAHJamisonMGBrancazioLRMyersERVenous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality200619451311131510.1016/j.ajog.2005.11.00816647915Search in Google Scholar
Ormesher L, Simcox L, Tower C, Greer IA. Management of inherited thrombophilia in pregnancy. Womens Health (Lond). 2016; 12(4): 433–441.OrmesherLSimcoxLTowerCGreerIAManagement of inherited thrombophilia in pregnancy201612443344110.1177/1745505716653702537327527638899Search in Google Scholar
Pabinger I, Grafenhofer H, Kaider A, Kyrle PA, Quehenberger P, Mannhalter C, et al. Risk of pregnancy-associated recurrent venous thromboembolism in women with a history of venous thrombosis. J Thromb Haemost. 2005; 3(5): 949–954.PabingerIGrafenhoferHKaiderAKyrlePAQuehenbergerPMannhalterCRisk of pregnancy-associated recurrent venous thromboembolism in women with a history of venous thrombosis20053594995410.1111/j.1538-7836.2005.01307.x15869590Search in Google Scholar
Bloomenthal D, von Dadelszen P, Liston R, Magee L, Tsang P. The effect of factor V Leiden carriage on maternal and fetal health. CMAJ. 2002; 167(1): 48–54.BloomenthalDvon DadelszenPListonRMageeLTsangPThe effect of factor V Leiden carriage on maternal and fetal health200216714854Search in Google Scholar
Elzein HO, Saad AA, Yousif AA, Elamin E, Abdalhabib EK, Elzaki SEG. Evaluation of Factor V Leiden and prothrombin G20210A mutations in Sudanese women with severe preeclampsia. Curr Res Transl Med. 2020; 68(2): 77–80.ElzeinHOSaadAAYousifAAElaminEAbdalhabibEKElzakiSEGEvaluation of Factor V Leiden and prothrombin G20210A mutations in Sudanese women with severe preeclampsia2020682778010.1016/j.retram.2019.08.00231501046Search in Google Scholar
Hoffbrand AV, Moss PAH, Editors. Platelets, blood coagulation and haemostasis. Hoffbrand's Essential Hematology, 7th ed. Chichester, West Sussex, UK: John Wiley & Sons, Ltd. 2016: 135–144.HoffbrandAVMossPAHEditors.7th ed.Chichester, West Sussex, UKJohn Wiley & Sons, Ltd.2016135144Search in Google Scholar
Kujovich JL. Factor v Leiden thrombophilia. Genet Med. 2011; 13(1): 1–16.KujovichJLFactor v Leiden thrombophilia201113111610.1097/GIM.0b013e3181faa0f221116184Search in Google Scholar
Sultan AA, Tata LJ, West J, Fiaschi L, Fleming KM, Nelson-Piercy C, et al. Risk factors for first venous thromboembolism around pregnancy: A population-based cohort study from the United Kingdom. Blood. 2013; 121(19): 3953–3961.SultanAATataLJWestJFiaschiLFlemingKMNelson-PiercyCRisk factors for first venous thromboembolism around pregnancy: A population-based cohort study from the United Kingdom2013121193953396110.1182/blood-2012-11-469551Search in Google Scholar
Barillari G, Londero AP, Brenner B, Nauffal D, Muñoz-Torrero JFS, Del Molino F, et al.; RIETE Registry. Recurrence of venous thromboembolism in patients with recent gestational deep vein thrombosis or pulmonary embolism: Findings from the RIETE Registry. Eur J Intern Med. 2016; 32: 53–59.BarillariGLonderoAPBrennerBNauffalDMuñoz-TorreroJFSDel MolinoFRIETE RegistryRecurrence of venous thromboembolism in patients with recent gestational deep vein thrombosis or pulmonary embolism: Findings from the RIETE Registry201632535910.1016/j.ejim.2016.02.013Search in Google Scholar
Knight M, UKOSS Antenatal pulmonary embolism: Risk factors, management and outcomes. BJOG. 2008; 115(4): 453–461.KnightMUKOSS Antenatal pulmonary embolism: Risk factors, management and outcomes2008115445346110.1111/j.1471-0528.2007.01622.xSearch in Google Scholar
Gader AA, Haggaz AED, Adam I. Epidemiology of deep venous thrombosis during pregnancy and puerperium in Sudanese women. Vasc Health Risk Manag. 2009; 5(1): 85–87.GaderAAHaggazAEDAdamIEpidemiology of deep venous thrombosis during pregnancy and puerperium in Sudanese women200951858710.2147/VHRM.S4196Search in Google Scholar
Babker AM, Ahmed IAM, Ismail M, Hassan FM, Osman AL, Kandakurti PK, et al. Lack of association between Factor V Leiden G1691A, prothrombin G20210A, MTHFC677T mutations, and early recurrent pregnancy loss in a group of Sudanese women. Open Access Maced J Med Sci. [Internet]. 2020; 8(B): 553–557.BabkerAMAhmedIAMIsmailMHassanFMOsmanALKandakurtiPKLack of association between Factor V Leiden G1691A, prothrombin G20210A, MTHFC677T mutations, and early recurrent pregnancy loss in a group of Sudanese women20208B55355710.3889/oamjms.2020.4384Search in Google Scholar
Nurk E, Tell GS, Refsum H, Ueland PM, Vollset SE. Factor V Leiden, pregnancy complications and adverse outcomes: The Hordaland Homocysteine Study. QJM. 2006; 99(5): 289–298.NurkETellGSRefsumHUelandPMVollsetSEFactor V Leiden, pregnancy complications and adverse outcomes: The Hordaland Homocysteine Study200699528929810.1093/qjmed/hcl040Search in Google Scholar
Elgari MM, Ibrahim NA, Muddathir ARM, Eltoom FM, Ibrahim IM. Frequency of thrombophilic gene mutations in patients with deep vein thrombosis and in women with recurrent pregnancy loss. Open Life Sci. 2017; 12(1): 162–166.ElgariMMIbrahimNAMuddathirARMEltoomFMIbrahimIMFrequency of thrombophilic gene mutations in patients with deep vein thrombosis and in women with recurrent pregnancy loss201712116216610.1515/biol-2017-0019Search in Google Scholar
Ahmed NA, Adam I, Elzaki SEG, Awooda HA, Hamdan HZ. Factor V Leiden G1691A and prothrombin G20210A polymorphisms in Sudanese women with pre-eclampsia, a case-control study. BMC Med Genet. 2019; 20(1): 16–20.AhmedNAAdamIElzakiSEGAwoodaHAHamdanHZFactor V Leiden G1691A and prothrombin G20210A polymorphisms in Sudanese women with pre-eclampsia, a case-control study2019201162010.1186/s12881-018-0737-zSearch in Google Scholar
Curigliano G, Mandalà M, Sbanotto A, Colleoni M, Ferretti G, Bucciarelli P, et al. Factor V Leiden mutation in patients with breast cancer with a central venous catheter: Risk of deep vein thrombosis. Support Cancer Ther [Internet]. 2006; 3(2): 98–102.CuriglianoGMandalàMSbanottoAColleoniMFerrettiGBucciarelliPFactor V Leiden mutation in patients with breast cancer with a central venous catheter: Risk of deep vein thrombosis2006329810210.3816/SCT.2006.n.005Search in Google Scholar
Monsuez J-J, Bouali H, Serve E, Boissonnas A, Alhenc-Gelas M. Deep venous thrombosis associated with Factor V Leiden, G20210A mutation, and protein S deficiency. Am J Med. 2003; 114(5): 421–422.MonsuezJ-JBoualiHServeEBoissonnasAAlhenc-GelasMDeep venous thrombosis associated with Factor V Leiden, G20210A mutation, and protein S deficiency2003114542142210.1016/S0002-9343(03)00004-4Search in Google Scholar
Franchini M. Utility of testing for factor V Leiden. Blood Transfus. 2012; 10(3): 257–259.FranchiniMUtility of testing for factor V Leiden2012103257259Search in Google Scholar
Farajzadeh M, Bargahi N, Poursadegh Zonouzi A, Farajzadeh D, Pouladi N. Polymorphisms in thrombophilic genes are associated with deep venous thromboembolism in an Iranian population. Meta Gene [Internet]. 2014; 2: 505–13.FarajzadehMBargahiNPoursadegh ZonouziAFarajzadehDPouladiNPolymorphisms in thrombophilic genes are associated with deep venous thromboembolism in an Iranian population201425051310.1016/j.mgene.2014.06.004428785225606434Search in Google Scholar
Jusić-Karić A, Terzić R, Jerkić Z, Avdić A, Podanin M. Frequency and association of 1691 (G>A) FVL, 20210 (G>A) PT and 677 (C>T) MTHFR with deep vein thrombosis in the population of Bosnia and Herzegovina. Balkan J Med Genet. 2016; 19(1): 43–49.Jusić-KarićATerzićRJerkićZAvdićAPodaninMFrequency and association of 1691 (G>A) FVL, 20210 (G>A) PT and 677 (C>T) MTHFR with deep vein thrombosis in the population of Bosnia and Herzegovina2016191434910.1515/bjmg-2016-0006502627927785407Search in Google Scholar